Commentary| Volume 48, ISSUE 6, P442-444, September 15, 2000

A consumer perspective concerning the diagnosis and treatment of bipolar disorder

      The National Depressive and Manic–Depressive Association (National DMDA) is concerned about the diagnosis and treatment of bipolar disorder. As the nation’s largest patient-directed, illness-specific organization, we represent the millions of people suffering from this disorder. As such, our perspectives may differ at times from those of physicians, researchers, and family members.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hirschfeld R.M.A.
        • Keller M.B.
        • Panico S.
        • Arons B.S.
        • Barlow D.
        • Davidoff F.
        • et al.
        The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression.
        JAMA. 1997; 277: 333-340
      1. National DMDA On-Line Survey of Those Who Have Been Treated for Depression (1999): Chicago: National Depressive and Manic–Depressive Association.

      2. National DMDA Support Group Compliance Survey (1998): Chicago: National Depressive and Manic–Depressive Association.